Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
02/14/2013 | CA2844275A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
02/14/2013 | CA2842853A1 Novel soft pde4 inhibitors |
02/13/2013 | EP2556081A2 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation |
02/13/2013 | EP2556068A1 P38 map kinase inhibitors |
02/13/2013 | EP2556056A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
02/13/2013 | EP2555755A2 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof |
02/13/2013 | EP2555754A2 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
02/13/2013 | CN102933579A New ccr2 receptor antagonists and uses thereof |
02/13/2013 | CN102933569A Method of preparing derivatives/oligomers of epicatechin and applications thereof |
02/13/2013 | CN102933206A Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
02/13/2013 | CN102924446A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
02/13/2013 | CN102924445A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
02/13/2013 | CN102924412A 2-cyanophenyl sulfonamide derivatives useful as pesticides |
02/13/2013 | CN102924410A Preparation method and intermediate of ramelteon |
02/13/2013 | CN102924366A Carbazole ketone intermediate containing multi-functional group structure and preparation method for carbazole ketone intermediate |
02/13/2013 | CN102060746B Synthesis method and intermediate of 3-(substituted dihydroisoindolinone-2-group)-2, 6-piperadinedione |
02/13/2013 | CN101969103B Light-emitting device material and light-emitting device |
02/13/2013 | CN101808999B Quinoline derivatives as 5HT5A receptor antagonists |
02/13/2013 | CN101111493B 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
02/12/2013 | US8372866 2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain |
02/12/2013 | US8372836 Spray dried formulation |
02/12/2013 | CA2596527C Igf-1r inhibitors |
02/12/2013 | CA2583920C Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
02/12/2013 | CA2571587C Quaternary salt ccr2 antagonists |
02/12/2013 | CA2480638C Substituted benzazoles and use thereof as raf kinase inhibitors |
02/07/2013 | WO2013018876A1 Organic metal complex and organic electroluminescence device using the complex |
02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |
02/07/2013 | WO2013017073A1 Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament |
02/07/2013 | WO2013017071A1 Alicyclic[c] benzopyrone derivatives and uses thereof |
02/07/2013 | WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use |
02/07/2013 | US20130035358 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
02/07/2013 | US20130035354 Aryl pyridine as aldosterone synthase inhibitors |
02/07/2013 | US20130035350 Novel Quinazoline Derivatives |
02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
02/07/2013 | US20130035329 Therapeutically active compositions and their methods of use |
02/07/2013 | US20130035323 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
02/07/2013 | US20130035304 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders |
02/07/2013 | US20130032787 Heterocyclic compound and organic light-emitting device including the same |
02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
02/06/2013 | EP2555271A1 Material for organic electroluminescence element, and organic electroluminescence element using same |
02/06/2013 | EP2552907A1 Pyridyltriazoles |
02/06/2013 | EP2552905A1 B-raf kinase inhibitors |
02/06/2013 | EP2552893A1 Antibacterial isoquinolin-3-ylurea derivatives |
02/06/2013 | EP2552890A1 Polycyclic tetracycline compounds |
02/06/2013 | EP2552886A1 Cytokine inhibitors |
02/06/2013 | EP2552214A1 Pyrazolyl-pyrimidines as kinase inhibitors |
02/06/2013 | EP2552208A1 Imidazolyl-imidazoles as kinase inhibitors |
02/06/2013 | CN1993327B 3-Carbamoyl-2-pyridone derivative |
02/06/2013 | CN102918034A Multisubstituted aromatic compounds as inhibitors of thrombin |
02/06/2013 | CN102918033A Aromatic monomers deriving from glycerol units, process for their preparation and use thereof for the preparation of water-soluble conjugated polymers |
02/06/2013 | CN102918027A Modulators of the gpr119 receptor and the treatment of disorders related thereto |
02/06/2013 | CN102917703A Novel EP4 agonist |
02/06/2013 | CN102917692A Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof |
02/06/2013 | CN102911164A Method for preparing lapatinib key intermediate |
02/06/2013 | CN102911163A Quinazoline derivatives, composition containing derivatives and pharmaceutical application of derivatives |
02/06/2013 | CN102911161A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
02/06/2013 | CN102911124A Hydroxy-pyrimidone compound and preparation method and application thereof |
02/06/2013 | CN102911117A Naphthylamine derivative and purpose thereof |
02/06/2013 | CN101490028B C-phenyl glycitol compound |
02/05/2013 | US8367838 Amines or amino alcohols as GLYT1 inhibitors |
02/05/2013 | US8367828 PPAR active compounds |
02/05/2013 | US8367710 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof |
02/05/2013 | US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |
02/05/2013 | US8367038 Therameutin modulators |
02/05/2013 | CA2591033C Heterocyclic aspartyl protease inhibitors |
02/05/2013 | CA2562401C Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
02/05/2013 | CA2508792C Heterocyclic compounds, methods of making them and their use in therapy |
01/31/2013 | WO2013016696A1 Antioxidant, neuroprotective and antineoplastic nanoparticles comprising a therapeutic agent on an amphiphilic spacer or an amphiphilic polymer |
01/31/2013 | WO2013016193A2 Activators of class i histone deacetlyases (hdacs) and uses thereof |
01/31/2013 | WO2013014445A1 Derivatives of phenyl (thio) urea deoxythymidine and use thereof as antimalarials |
01/31/2013 | WO2013014165A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
01/31/2013 | WO2013014039A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors |
01/31/2013 | WO2013014038A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors |
01/31/2013 | US20130030192 Method of Synthesizing Acetonide-Protected Catechol-Containing Compounds and Intermediates Produced Therein |
01/31/2013 | US20130029987 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
01/31/2013 | US20130029981 Compounds, compositions, and methods for controlling biofilms |
01/31/2013 | US20130029979 Fused bicyclic compound |
01/31/2013 | US20130029978 Novel aryl urea derivative |
01/31/2013 | US20130029975 Cgrp antagonists |
01/31/2013 | US20130029964 [5, 6] heterocyclic compound |
01/31/2013 | US20130029963 1,2,4-triazine-4-amine derivatives |
01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
01/31/2013 | US20130029942 Compounds and therapeutical uses thereof |
01/31/2013 | US20130028966 Broad Spectrum Antiviral and Antiparasitic Agents |
01/31/2013 | US20130028859 Hepatitis C Virus Inhibitors |
01/31/2013 | US20130028843 Kallikrein 7 modulators |
01/31/2013 | CA2842830A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof,and use thereof as herbicides and plant growth regulators |
01/31/2013 | CA2842524A1 Activators of class i histone deacetlyases (hdacs) and uses thereof |
01/30/2013 | EP2550269A1 Process and intermediates for preparing lapatinib |
01/30/2013 | EP2550267A1 Analogues for the treatment or prevention of flavivirus infections |
01/30/2013 | EP2550265A1 Pyridazine compounds for controlling invertebrate pests |
01/30/2013 | CN102906087A Process for the preparation of chiral triazolones |
01/30/2013 | CN102906085A 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
01/30/2013 | CN102906074A Fused imidazole derivative |
01/30/2013 | CN102898432A Tricyclic compound |
01/30/2013 | CN102898422A Method for preparing difenoconazole |
01/30/2013 | CN102898408A Benzopyran compounds, preparation method and applications thereof |
01/30/2013 | CN102898386A Quinazoline derivative, preparation method, intermediate, composition and application |
01/30/2013 | CN102898385A Synthesis of 4(3H)-quinazolone through catalysis of recyclable copper oxide |